Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Health » Health Care » Health Care Costs: Causes, Effects and Control Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Central Asia: Perspectives and Present Challenges
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to SCREENING COLONOSCOPY IN GERMANY. A COST-SAVING ANALYSIS pp. 195-208
Tell A Friend
Tell someone you know about this product.
Authors:  Andreas Sieg, and Hermann B(Andreas Sieg, Gastroenterology, Heidelberg, Univ. of Heidelberg, Hermann Brenner, Div. of Clin. Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany)
Germany is one of the countries with the highest incidence (73/100.000 in men and
50/100.000 in women with 71.400 new cases per year) and mortality (30.000 deaths per year)
of colorectal cancer (CRC) (1,2), which constitutes a major public health burden. Screening
colonoscopy was introduced into the National Cancer Prevention Program in Germany in
2002 (3) even though results from randomised controlled studies on its effect on incidence
and mortality of colorectal cancer were not yet available. However, evidence from
observational studies strongly suggests that this screening tool may in fact be very effective.
Colonoscopy is the definitive diagnostic method of all studies with the fecal-occult blood test
(4-7). Sigmoidoscopy studies were effective (8-10) and it is reasonable to anticipate that
colonoscopy is more sensitive than sigmoidoscopy (11). In case-control studies in the U.S.
(12) and Germany (13) colonoscopy was associated with a strongly reduced probability to
develop colorectal cancer. Furthermore the results from the National Polyp Study in the U.S.
showed that polypectomy reduced the incidence of CRC between 76 to 90 percent (14). In
Germany, screening colonoscopy is offered to every person from 55 years. A second
colonoscopy will be offered after 10 years if no neoplasms are found and the screenee is
below the age of 65 years at first screening colonoscopy. A first evaluation of the results of
screening colonoscopy showed high prevalence of adenomas and colorectal cancer (15). Costeffectiveness
analyses in the U.S. showed that CRC screening is cost-effective compared with
no screening at ratios between $10.000 and $25.000 per live-year saved (16). 

Available Options:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020